Noronha, V.
Patil, V. M.
Menon, N. S.
Joshi, A.
Goud, S.
More, S.
Kannan, S.
Pawar, A.
Nakti, D.
Yadav, A.
Shah, S.
Mahajan, A.
Janu, A.
Kumar, R.
Tibdewal, A.
Mummudi, N.
Agarwal, J. P.
Banavali, S. D.
Prabhash, K.
Funding for this research was provided by:
Tata Memorial Centre
Article History
Received: 27 February 2022
Accepted: 30 April 2022
First Online: 26 May 2022
Declarations
:
: The study was approved by the Institutional Ethics Committee (IEC) of the Tata Memorial Center (Project number 155, approved by IEC-III).
: Unrelated to the current study, Dr. Vanita Noronha has received research funding from Amgen, Sanofi India Ltd., Dr. Reddy’s Laboratories Inc., Intas Pharmaceuticals and Astra Zeneca Pharma India Ltd. (all research grants paid to the institution). Unrelated to the current study, Dr. Kumar Prabhash has received research funding from Dr. Reddy’s Laboratories Inc., Fresenius Kabi India Pvt. Ltd., Alkem Laboratories, Natco Pharma Ltd., BDR Pharmaceuticals Intl. Pvt. Ltd, and Roche Holding AG (all research grants paid to the institution). All the other authors declared no conflicts of interest.